Welcome to Metaverse, Nebius (NASDAQ:…
…
TRENDING
27.43 USD
0.4758 USD
0.008 USD
0.0282 USD
0.0209 USD
0.2854 USD
0.054 USD
6.18 USD
0.411 USD
0.0651 USD
4.47 USD
0.99 USD
15.53 USD
0.28 USD
0.089 USD
3.16 USD
0.1916 USD
4.18 USD
20.27 USD
2.48 USD
Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion Merck (NYSE: MRK) announced it will acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, valuing the transaction at approximately $9.2 billion. The acquisition centers on Cidara’s lead candidate CD388, an investigational antiviral agent currently in Phase 3 trials for influenza prevention. CD388 is designed to …